E board review in Breast Cancer February 2008 Reading List

September 24, 2010

html>body {font-size: small;}a:link {color: #990000}a:visited {color: #990000;}a:hover {color: #cccccc}table td {padding: 0pt; border-width: 0; vertical-align: top; font-family: arial, helvetica, verdana, sans-serif;}td#footer {background: #ccffcc; padding: 10px; font: normal 90% arial, helvetica, sans-serif; vertical-align: middle;}td#sponsor a {color: #FFF;}td#sponsor a:visited {color: #FFF;}td#sponsor {background: #333399; width: 625px; height: 10px; padding: 5px; font: 100% verdana, arial, helvetica ; color: #ffffff;}td#date {background: #cccccc; width: 625px; height: 10px; padding: 5px 5px; font: bold 110% verdana, arial, helvetica ; color: #000000;}b#ge {font: italic bold 100% verdana, arial, helvetica;}td#content {font: normal 10pt/14pt arial, verdana, helvetica; padding: 5px;}h3 {font: bold 120% verdana, arial, helvetica, sans-seif; color: #000000; padding: 5px;}h4 {font: normal 120% verdana, arial, helvetica, sans-seif; color: #000000;}h5 {font: times,serif; color: #990000;}div#links {position: absolute; top: 40px left: 0; width: 200px;}div#links a {color: #ffcc00; display: block; padding: 5px 10px; margin: 0 0 2px; border-width=0; text-align: center; font: bold 17px/17px sans-serif; text-decoration: none;}div#links a:visited:hover {color: #cccccc;}a.bluelink:link, a.bluelink:visited { color:#036; font:normal 10px "Lucida Grande", "Lucida Sans Unicode", verdana, lucida, sans-serif; text-decoration :underline;}.menunav { border-top: 2px solid #5A6565; background: #919898; padding: 3px 3px 3px 3px; border-bottom: 2px solid #ffffff; }.menunav_selected { color: #FFFFFF;background: #B2B7B7; border-top: 2px solid #5A6565; padding: 3px 3px 3px 3px; border-bottom: 2px solid #ffffff; }.menunav_selected_sub { background: #D3D6D6; padding: 3px 3px 3px 15px; }div#menu_menu {width: 90%;border: 1px solid #333;padding: 10px 10px 0px 10px;}div#menu_menu a { padding: 3px 0 3px 0; border-top: 1px solid #990000; text-decoration: none;color:#000; font-family:arial, helvetica, sans-serif; font-size: x-small; display: block; text-align: left; vertical-align: bottom;}div#menu_menu a:hover {color: #FFFFFF;background: #990000;}#menu_menu LI { margin: 10; padding: 0; display: inline; border-bottom: 2px solid #ffffff; }div#apply {width: 100%;border: 0px solid #333;padding: 0px 0px 0px 0px;background: #008A45;}div#apply a { border-top: 1px solid #990000; text-decoration: none;color:#FFF0D0; font-family:arial, helvetica, sans-serif; font-size: x-small; display: block; text-align: left; vertical-align: bottom;}div#apply a:hover {color: #FFFFFF;background: #990000;}#apply LI { margin: 10; padding: 0; display: inline; border-bottom: 2px solid #ffffff; } #menurightcolumn { width: 220px; \width: 240px; w\idth: 220px; padding: 10px; text-align: left; margin: 0px; float: right; }.clearer {clear: both;}ol {list-style-type: decimal; margin-left:20px;}

 

Suggested Reading List

Print Entire Reading List

Reducing Risk/Increasing Survival
(Questions 1–7)

Adjuvant Therapy
(Questions 8–13)

Treatment Results
(Questions 14–20)

Advanced and Recurrent Disease
(Questions 21–32)

Breast Cancer Subtypes
(Questions 33–36)